AI in Biotechnology Market worth $22,716.5 million by 2035 with 18.5% CAGR | MarketsandMarkets (TM).

In November 2025, Cytokinetics announced that additional late-stage aficamten trial data were presented at major cardiovascular conferences, highlighting the drug's positive effects across multiple ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Insight Molecular Diagnostics Inc. is rated Hold due to upcoming catalysts & pending FDA submission for GraftAssureDx. Read ...

Nvidia (NVDA) investors already know that surging demand for artificial intelligence (AI) hardware has turned the chipmaker ...

HeartBeam, Inc. , a medical technology company focused on transforming cardiac care by providing powerful personalized insights, has reported its financial and operational results for the third ...

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, ...